FUNDAMENTALS
1. Reinsurance?
보험사가 인수한 중대형 Risk의 상당부분 혹은 일부를 다른 보험회사에 전가하여 보험사업의 안정화 도모.
Reinsurance company= Assuming company = Reinsurer
2. Retention?
The amount of risk not reinsured by the cedant. (cedant=insurer)
3. Cession?
The amount transferred. (원보험자가 재보험자에게 전가한 risk
Ⅰ-1. Study Background & Purpose
Study Background
Now, When people take advantage of hospital, patients undergo discomfort in various aspects. One of the discomforts is that patients directly delivery examination result from existing hospital to new hospital., As patients displace hospital. And when patient putout to relieve the discomfort. medical document, patient directly visit treated hos
5.2 Drug Delivery System
5.2.1 Advantage of Nano-drug delivery system
By diagnosis, and for treatment, we need enhanced drug delivery system. Drug delivery system of these days is just eat and let it flow through the body. It is not good at efficiency. Because the digestive system sometimes digest and remove the drug before it reaches to the target.
For enhancing the efficiency of drug
COMT Inhibitors
▶ 크롬친화성 세포종 환자에 투여시 고혈압 위기의 위험을 증가
▶ Non-selective MAO inhibitors (phenelzine, tranylcipromine)및
Selective MAO-A,B inhibitors 와는 병용투여 금지.
▶ Cathechol기를 포함한 약물의 대사를 간섭하여 그 작용을 증강시킬 수 있다.
Amantadine
▶ 알려진 연장된 QT간격(Bazett Q
terminology1325.html)에서는 “환자의 치료와
관리를 위해 과학적 결과를 찾아내어 평가하고 적용하는 과정이다”라고 했다.
여기에서 다룰 2가지 주제
①RU와 EBP의 차이(Brown, 1999;Jennings & Loan 2001; McGuire & Harwood, 2000)
②EBM, EBN(Evidence-based nursing), EBP(Jennings & Loan, 2001)의 정의
RU와 EBP 둘다 지식을 이용하는 방법